News from gemoab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

15 May, 2020, 13:00 BST GEMoaB Announces Data Presentations Supporting Key Features of Its UniCAR Platform At the Upcoming American Association for Cancer Research (AACR) Meeting II

GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to-treat cancers, today announced...


17 Mar, 2020, 14:00 GMT GEMoaB Announces Publication of Pre-Clinical Proof-of-Concept Data on UniCAR-modified off-the-shelf Natural Killer Cells in 'Nature Scientific Reports'

GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to-treat cancers, today announced that...


12 Mar, 2020, 13:00 GMT GEMoaB Announces Internationally Renowned Experts to Newly Formed Strategic and Scientific Advisory Board

GEMoaB, a biopharmaceutical company focused on the development of next generation immunotherapies for hard-to-treat cancers, today announced the...


09 Mar, 2020, 14:00 GMT GEMoaB Announces First Patient Apheresed in a Phase IA Study With Lead Product Candidate From Rapidly Switchable Universal CAR-T Platform (UniCAR) in CD123 Positive Relapsed/Refractory Acute Leukemias

GEMoaB, a biopharmaceutical company focused on the development of next generation immunotherapies for hard-to-treat cancers, today announced that it...